Introduction
Hypertension is defined as office BP ≥ 140/90 mmHg (home ≥ 135/85, 24-h ambulatory ≥ 130/80). Treatment aims to prevent stroke, myocardial infarction, heart failure and kidney disease; each 10 mmHg fall in systolic BP cuts major cardiovascular events by about 20%.
Targets (ESC/ESH)
- Most adults: < 140/90, and if tolerated systolic 120–130 mmHg (ESC 2024 suggests 120–129 for most).
- Elderly and frail: individualise; avoid orthostatic hypotension.
Lifestyle (for everyone)
Salt < 5 g/day, weight loss, regular exercise, alcohol limits, stop smoking, diet rich in fruit and vegetables (DASH).
Drug treatment
Five main classes reduce cardiovascular events and are first line:
Strategy
- Start most patients on a two-drug combination in a single pill: ACE inhibitor or ARB + CCB or diuretic (low-dose monotherapy only for grade 1 low-risk, very old or frail patients).
- If not controlled: triple combination A + C + D in one pill.
- Resistant hypertension (uncontrolled on 3 drugs including a diuretic): add spironolactone (or β-blocker, α-blocker); check adherence and secondary causes.
Choice in special situations
Hypertensive emergency (BP very high with acute organ damage): IV labetalol, nicardipine, nitroglycerin or urapidil; lower by no more than 25% in the first hour.
Start with a single-pill combination of an ACE inhibitor or ARB with a calcium channel blocker or thiazide; add the third, then spironolactone.